Prophylactic zinc supplementation reduces bacterial load and improves survival in a murine model of sepsis

Pediatric Critical Care Medicine

Volumn 13, Issue 5, 2012, Pages

  Nowak, Jeffrey E ^a   Harmon, Kelli ^a   Caldwell, Charles C ^a   Wong, Hector R ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

inflammation; phagocytosis; sepsis; supplementation; zinc

Indexed keywords

CD69 ANTIGEN; GLUCONATE ZINC; HERMES ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; L SELECTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL LOAD; CONTROLLED STUDY; ENZYME ACTIVITY; ESCHERICHIA COLI; IMMUNOPHENOTYPING; IMMUNOREACTIVITY; IN VIVO STUDY; INFLAMMATION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PERITONITIS; PHAGOCYTOSIS; PRIORITY JOURNAL; SEPSIS; STAPHYLOCOCCUS AUREUS; SURVIVAL TIME;

ANIMALS; BACTERIAL LOAD; DISEASE MODELS, ANIMAL; FECES; GLUCONATES; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED C57BL; PERITONITIS; PHAGOCYTOSIS; SEPSIS; SURVIVAL RATE; TRACE ELEMENTS;

EID: 84866358089     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/PCC.0b013e31824fbd90     Document Type: Article

References (28)

1. Haase H, Rink L: Functional signifcance of zinc-related signaling pathways in immune cells. Annu Rev Nutr 2009; 29:133-152
2. Rink L, Haase H: Zinc homeostasis and immunity. Trends Immunol 2007; 28:1-4
3. Cvijanovich NZ, King JC, Flori HR, et al: Zinc homeostasis in pediatric critical illness. Pedi-atr Crit Care Med 2009; 10:29-34
4. Heyland DK, Jones N, Cvijanovich NZ, et al: Zinc supplementation in critically ill patients: A key pharmaconutrient? JPEN J Parenter Enteral Nutr 2008; 32:509-519
5. Wynn J, Cornell TT, Wong HR, et al: The host response to sepsis and developmental impact. Pediatrics 2010; 125:1031-1041
6. Cornell TT, Wynn J, Shanley TP, et al: Mechanisms and regulation of the gene-expression response to sepsis. Pediatrics 2010; 125:1248-1258
7. Wheeler DS, Zingarelli B, Wheeler WJ, et al: Novel pharmacologic approaches to the management of sepsis: Targeting the host infammatory response. Recent Pat Infamm Allergy Drug Discov 2009; 3:96-112
8. Wong HR, Shanley T P, Sakthivel B, et al; Genomics of Pediatric SIRS/Septic Shock Investigators: Genome-level expression profles in pediatric septic shock indicate a role for altered zinc homeostasis in poor outcome. Physiol Genomics 2007; 30: 146-155
9. Wong HR, Freishtat RJ, Monaco M, et al: Leukocyte subset-derived genomewide expression profles in pediatric septic shock. Pediatr Crit Care Med 2010; 11:349-355
10. Wong HR, Cvijanovich N, Lin R, et al: Iden-tifcation of pediatric septic shock subclasses based on genome-wide expression profling. BMC Med 2009; 7:34
11. Wong HR, Cvijanovich N, Allen GL, et al; Genomics of Pediatric SIRS/Septic Shock Investigators: Genomic expression profl-ing across the pediatric systemic infamma-tory response syndrome, sepsis, and septic shock spectrum. Crit Care Med 2009; 37: 1558-1566
12. Shanley TP, Cvijanovich N, Lin R, et al: Genome-level longitudinal expression of signaling pathways and gene networks in pediatric septic shock. Mol Med 2007; 13: 495-508
13. Cvijanovich N, Shanley TP, Lin R, et al; Genomics of Pediatric SIRS/Septic Shock Investigators: Validating the genomic signature of pediatric septic shock. Physiol Genomics 2008; 34:127-134
14. Besecker BY, Exline MC, Hollyfeld J, et al: A comparison of zinc metabolism, infam-mation, and disease severity in critically ill infected and noninfected adults early after intensive care unit admission. Am J Clin Nutr 2011; 93:1356-1364
15. Nowak JS, Wong HR: Novel therapeutic agents in pediatric sepsis-zinc. Open Infamm J 2011; 4:107-111
16. Wynn JL, Scumpia PO, Winfeld RD, et al: Defective innate immunity predisposes murine neonates to poor sepsis outcome but is reversed by TLR agonists. Blood 2008; 112:1750-1758
17. Wynn JL, Scumpia PO, Delano MJ, et al: Increased mortality and altered immunity in neonatal sepsis produced by generalized peritonitis. Shock 2007; 28:675-683
18. Solan PD, Piraino G, Hake PW, et al: Liver X receptor a activation with the synthetic ligand T0901317 reduces lung injury and infammation after hemorrhage and resuscitation via inhibition of the nuclear factor κB pathway. Shock 2011; 35:367-374
19. Caldwell CC, Kojima H, Lukashev D, et al: Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions. J Immunol 2001; 167:6140-6149
20. Bao S, Liu MJ, Lee B, et al: Zinc modulates the innate immune response in vivo to poly-microbial sepsis through regulation of NF-kappaB. Am J Physiol Lung Cell Mol Physiol 2010; 298:L744-L754
21. Knoell DL, Julian MW, Bao S, et al: Zinc def-ciency increases organ damage and mortality in a murine model of polymicrobial sepsis. Crit Care Med 2009; 37:1380-1388
22. King LE, Osati-Ashtiani F, Fraker PJ: Apop-tosis plays a distinct role in the loss of precursor lymphocytes during zinc defciency in mice. J Nutr 2002; 132:974-979
23. Kitamura H, Morikawa H, Kamon H, et al: Toll-like receptor-mediated regulation of zinc homeostasis infuences dendritic cell function. Nat Immunol 2006; 7:971-977
24. Krones C, Klosterhalfen B, Fackeldey V, et al: Deleterious effect of zinc in a pig model of acute endotoxemia. J Invest Surg 2004; 17:249-256
25. Shankar AH, Prasad AS: Zinc and immune function: The biological basis of altered resistance to infection. Am J Clin Nutr 1998; 68(2 Suppl):447S-463S
26. Bhutta ZA, Nizami SQ, Isani Z: Zinc supplementation in malnourished children with persistent diarrhea in Pakistan. Pediatrics 1999; 103:e42
27. Ruel MT, Rivera JA, Santizo MC, et al: Impact of zinc supplementation on morbidity from diarrhea and respiratory infections among rural Guatemalan children. Pediatrics 1997; 99:808-813
28. Carcillo JA, Dean JM, Holubkov R, et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Collaborative Pediatric Critical Care Research Network (CPCCRN): The randomized comparative pediatric critical illness stress-induced immune suppression (CRISIS) prevention trial. Pediatr Crit Care Med 2012; 13:165-173